EHS
EHS

Small molecule IBD treatment begins phase 1 trial

Jean-Frederic Colombel
A phase 1 clinical trial to test the safety and tolerability of BT-11, an investigational small molecule for the treatment of inflammatory bowel disease, is currently under way.
According to the manufacturer, Landos Biopharma, BT-11 has shown safety and efficacy in multiple preclinical trials. Landos hopes the drug will serve as an alternative to current therapies without many of the same side effects, according to a press release.
“Current treatment options for IBD have a number of drawbacks as they only benefit a limited number of patients, lose response
EHS
Back to top button